The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Cook, Diana Louise
    Clinical Trials Director born in January 1968
    Individual (1 offspring)
    Officer
    2002-05-29 ~ dissolved
    OF - Director → CIF 0
    Cook, Diana Louise
    Clinical Trials Director
    Individual (1 offspring)
    Officer
    2002-05-29 ~ dissolved
    OF - Secretary → CIF 0
    Diana Louise Cook
    Born in January 1968
    Individual (1 offspring)
    Person with significant control
    2016-04-06 ~ dissolved
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 2
    Cook, Robert Charles, Doctor
    Doctor born in June 1952
    Individual (1 offspring)
    Officer
    2002-05-29 ~ dissolved
    OF - Director → CIF 0
    Doctor Robert Charles Cook
    Born in June 1952
    Individual (1 offspring)
    Person with significant control
    2016-04-06 ~ dissolved
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
Ceased 2
  • 1
    Traylor, Kerry Marie
    Individual
    Officer
    2002-05-29 ~ 2002-05-29
    OF - Secretary → CIF 0
  • 2
    Wilkins, Graham David
    Chartered Accountant born in October 1955
    Individual (14 offsprings)
    Officer
    2002-05-29 ~ 2002-05-29
    OF - Director → CIF 0
parent relation
Company in focus

PENINSULA MEDICAL RESEARCH LIMITED

Standard Industrial Classification
72190 - Other Research And Experimental Development On Natural Sciences And Engineering
Brief company account
Property, Plant & Equipment
0 GBP2021-05-31
68 GBP2020-05-31
Debtors
Current
0 GBP2021-05-31
1,955 GBP2020-05-31
Cash at bank and in hand
30,314 GBP2021-05-31
30,446 GBP2020-05-31
Creditors
Non-current
0 GBP2021-05-31
-15,000 GBP2020-05-31
Net Assets/Liabilities
1,326 GBP2021-05-31
5,273 GBP2020-05-31
Equity
Called up share capital
4 GBP2021-05-31
4 GBP2020-05-31
Retained earnings (accumulated losses)
1,322 GBP2021-05-31
5,269 GBP2020-05-31
Equity
1,326 GBP2021-05-31
5,273 GBP2020-05-31
Average Number of Employees
22020-06-01 ~ 2021-05-31
22019-06-01 ~ 2020-05-31
Intangible Assets - Gross Cost
Goodwill
30,716 GBP2021-05-31
30,716 GBP2020-05-31
Intangible Assets - Gross Cost
30,716 GBP2021-05-31
30,716 GBP2020-05-31
Intangible Assets - Accumulated Amortisation & Impairment
Goodwill
30,716 GBP2021-05-31
30,716 GBP2020-05-31
Intangible Assets - Accumulated Amortisation & Impairment
30,716 GBP2021-05-31
30,716 GBP2020-05-31
Intangible Assets
Goodwill
0 GBP2021-05-31
0 GBP2020-05-31
Intangible Assets
0 GBP2021-05-31
0 GBP2020-05-31
Property, Plant & Equipment - Gross Cost
Office equipment
8,317 GBP2021-05-31
8,317 GBP2020-05-31
Property, Plant & Equipment - Gross Cost
8,317 GBP2021-05-31
8,317 GBP2020-05-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Office equipment
8,317 GBP2021-05-31
8,249 GBP2020-05-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
8,317 GBP2021-05-31
8,249 GBP2020-05-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Office equipment
68 GBP2020-06-01 ~ 2021-05-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
68 GBP2020-06-01 ~ 2021-05-31
Property, Plant & Equipment
Office equipment
0 GBP2021-05-31
68 GBP2020-05-31
Bank Borrowings/Overdrafts
Current
15,000 GBP2021-05-31
0 GBP2020-05-31
Amounts owed to directors
Current
1,905 GBP2021-05-31
1,282 GBP2020-05-31
Accrued Liabilities/Deferred Income
Current
1,920 GBP2021-05-31
1,868 GBP2020-05-31
Corporation Tax Payable
Current
10,163 GBP2021-05-31
9,046 GBP2020-05-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
2 shares2021-05-31
Par Value of Share
Class 1 ordinary share
1 GBP2020-06-01 ~ 2021-05-31
Nominal value of allotted share capital
Class 1 ordinary share
2 GBP2020-06-01 ~ 2021-05-31
2 GBP2019-06-01 ~ 2020-05-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
1 shares2021-05-31
Par Value of Share
Class 2 ordinary share
1 GBP2020-06-01 ~ 2021-05-31
Nominal value of allotted share capital
Class 2 ordinary share
1 GBP2020-06-01 ~ 2021-05-31
1 GBP2019-06-01 ~ 2020-05-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
1 shares2021-05-31
Par Value of Share
Class 3 ordinary share
1 GBP2020-06-01 ~ 2021-05-31
  • PENINSULA MEDICAL RESEARCH LIMITED
    Info
    Registered number 04449959
    C/o Francis Clark Llp North Quay House, Sutton Harbour, Plymouth PL4 0RA
    Private Limited Company incorporated on 2002-05-29 and dissolved on 2022-12-13 (20 years 6 months). The company status is Dissolved.
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.